公司资料
Lyra Therapeutics 股价、新闻与催化剂
- 股票代码:
- LYRA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.03 USD (0.00%)
收盘价
最后更新: 2026年11月19日
—
市值
股价为何变动
截至 2026年11月19日,LYRA 股价变化不大,收于 $0.0300。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Lyra Therapeutics is an otolaryngology company focused on chronic rhinosinusitis and upper-airway disease. Its platform uses localized delivery to treat difficult ENT conditions.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Lyra sits in specialty biotechnology.
商业模式特征
The company depends on clinical validation, delivery technology, and the ability to build a niche ENT franchise.
生物医药行业定位
Lyra is a niche ENT catalyst name whose stock is driven by clinical and regulatory progress.
未来催化剂
- Lyra’s catalysts are its GI-surgery and reflux platform, along with any commercial update that shows the device base is still growing. The story is about procedure adoption more than binary events.
近期新闻
新闻标题由机器翻译,详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。
